| Literature DB >> 27568568 |
Yoshihiro Kawasaki1, Mimon Komiya2, Kosuke Matsumura2, Lumi Negishi2, Sakiko Suda2, Masumi Okuno2, Naoko Yokota3, Tomoya Osada2, Takeshi Nagashima4, Masaya Hiyoshi5, Mariko Okada-Hatakeyama4, Joji Kitayama5, Katsuhiko Shirahige3, Tetsu Akiyama6.
Abstract
Aberrant activation of Wnt/β-catenin signaling is a major driving force in colon cancer. Wnt/β-catenin signaling induces the expression of the transcription factor c-Myc, leading to cell proliferation and tumorigenesis. c-Myc regulates multiple biological processes through its ability to directly modulate gene expression. Here, we identify a direct target of c-Myc, termed MYU, and show that MYU is upregulated in most colon cancers and required for the tumorigenicity of colon cancer cells. Furthermore, we demonstrate that MYU associates with the RNA binding protein hnRNP-K to stabilize CDK6 expression and thereby promotes the G1-S transition of the cell cycle. These results suggest that the MYU/hnRNP-K/CDK6 pathway functions downstream of Wnt/c-Myc signaling and plays a critical role in the proliferation and tumorigenicity of colon cancer cells.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27568568 DOI: 10.1016/j.celrep.2016.08.015
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423